Member
Claryx
Claryx is building the hospital immune system, reading the genomes of confirmed patient infections, linking related cases as outbreaks, and tracing each back to its likely source. When that source is in the building (a sink, a shared piece of equipment, a particular room), Claryx finds it by matching the patient's strain against a digital twin of the hospital's microbiome, sequenced from its air, its water and its surfaces, all on proprietary chemistry cheap enough to run continuously. Claryx is based in New York and live across multiple health systems.
Industries
N/A
Nr. of Employees
small (1-50)
Claryx is currently seeking investment
Claryx is seeking a seed investment in the range of 5m-20m
Expertise Areas
- Infectious disease surveillance
- Environmental pathogen monitoring
- Genomic data analysis
- Antimicrobial resistance research
Key Technologies
- Genomic sequencing
- Environmental DNA (eDNA) analysis
- Bioinformatics
- Genome mining
Key People
Chief Science Officer
Chief Executive Officer
Chief Science Officer
Chief Executive Officer